{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T07:07:15Z","timestamp":1794812835046,"version":"4.9.1"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007833","name":"Hamad Medical Corporation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007833","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Type 2 Diabetes (T2D) and Alzheimer\u2019s Disease (AD) share common risk factors that can be seen through T2D nearly doubling an individual\u2019s likelihood of developing AD. Some AD patients show signs of metabolic dysfunction as well. This review focuses on the potential mechanisms associated with these two diseases, like insulin resistance, inflammation, oxidative damage, mitochondrial injury, and cell death. One of the notable elements in this connection is the \u201cbrain insulin resistance,\u201d most frequently named as \u201ctype 3 diabetes,\u201d which impairs glucose metabolism and facilitates amyloid beta (A\u03b2) plaque synthesis while reducing the action of insulin-degrading enzyme (IDE). Moreover, the overactivity of glycogen synthase kinase-3 beta (GSK-3\u03b2) also triggers taurine protein pathology. Raised concentrations of glucose in blood can produce advanced glycation end products (AGEs), which further exacerbate neuroinflammation in tandem with the mitigation of neurotoxic A\u03b2 oligomers. Inflammation and subsequent damage to mitochondria lead to the dissolution of synapses. Current vascular insults include the breakdown of the blood-brain barrier (BBB) and decreased brain perfusion, along with other contributory factors to conditions conducive to neurotoxicity. Recently, novel therapies are emerging, including GLP-1 agonists, intranasal insulin, and mitochondrial antioxidants, that show surprising results for treating both conditions, but on the contrary, bioavailability and the timing of interventions remain a big challenge in the management of these diseases. Eventually, further research should center on understanding the mechanisms of integration along with the development of molecular biology, neuroimaging, and outcome-driven treatment strategies. Comprehensive strategies that exist between T2D-AD for integration and preservation of brain and metabolic health are addressed in this review.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1007\/s11011-025-01700-z","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T09:24:47Z","timestamp":1758878687000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["From metabolic dysregulation to neurodegenerative pathology: the role of hyperglycemia, oxidative stress, and blood-brain barrier breakdown in T2D-driven Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"40","author":[{"given":"Ahmad","family":"Raza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shafaq","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samar","family":"Imran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Haroon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azeen","family":"Razzaq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2627-685X","authenticated-orcid":false,"given":"Javed","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brijesh","family":"Sathian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"issue":"7","key":"1700_CR1","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.4239\/wjd.v15.i7.1430","volume":"15","author":"MMI Abdalla","year":"2024","unstructured":"Abdalla MMI (2024) Insulin resistance as the molecular link between diabetes and Alzheimer\u2019s disease. World J Diabetes 15(7):1430\u20131447","journal-title":"World J Diabetes"},{"issue":"6","key":"1700_CR2","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.3390\/ph3061949","volume":"3","author":"MA Ajmone-Cat","year":"2010","unstructured":"Ajmone-Cat MA, Bernardo A, Greco A, Minghetti L (2010) Non-steroidal anti-inflammatory drugs and brain inflammation: effects on microglial functions. Pharmaceuticals (Basel) 3(6):1949\u20131965. https:\/\/doi.org\/10.3390\/ph3061949","journal-title":"Pharmaceuticals (Basel)"},{"issue":"22","key":"1700_CR3","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11226742","volume":"11","author":"A Atlante","year":"2022","unstructured":"Atlante A, Amadoro G, Latina V, Valenti D (2022) Therapeutic potential of targeting mitochondria for Alzheimer\u2019s disease treatment. J Clin Med 11(22):6742","journal-title":"J Clin Med"},{"issue":"19","key":"1700_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10194360","volume":"10","author":"I Avitan","year":"2021","unstructured":"Avitan I, Halperin Y, Saha T et al (2021) Towards a consensus on Alzheimer\u2019s disease comorbidity?? J Clin Med 10(19):4360. https:\/\/doi.org\/10.3390\/jcm10194360","journal-title":"J Clin Med"},{"issue":"10","key":"1700_CR5","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1038\/s41593-020-0687-6","volume":"23","author":"MA Busche","year":"2020","unstructured":"Busche MA, Hyman BT (2020) Synergy between amyloid-\u03b2 and tau in Alzheimer\u2019s disease. Nat Neurosci 23(10):1183\u20131193. https:\/\/doi.org\/10.1038\/s41593-020-0687-6","journal-title":"Nat Neurosci"},{"issue":"1","key":"1700_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-024-01346-4","volume":"16","author":"F Cao","year":"2024","unstructured":"Cao F, Yang F, Li J, Guo W, Zhang C, Gao F, Sun X, Zhou Y, Zhang W (2024) The relationship between diabetes and the dementia risk: a meta-analysis. Diabetol Metab Syndr 16(1):101. https:\/\/doi.org\/10.1186\/s13098-024-01346-4","journal-title":"Diabetol Metab Syndr"},{"issue":"5","key":"1700_CR7","doi-asserted-by":"crossref","DOI":"10.1111\/acel.14106","volume":"23","author":"A Carey","year":"2024","unstructured":"Carey A, Parodi-Rullan R, Vazquez-Torres R, Canepa E, Fossati S (2024) Homocysteine potentiates amyloid \u03b2-induced death receptor 4- and 5-mediated cerebral endothelial cell apoptosis, blood\u2013brain barrier dysfunction, and angiogenic impairment. Aging Cell 23(5):e14106","journal-title":"Aging Cell"},{"key":"1700_CR8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s43162-021-00081-w","volume":"33","author":"A Chakraborty","year":"2021","unstructured":"Chakraborty A, Sami SA, Marma KKS (2021) A comprehensive review on RAGE-facilitated pathological pathways connecting Alzheimer\u2019s disease, diabetes mellitus, and cardiovascular diseases. Egypt J Intern Med 33:47","journal-title":"Egypt J Intern Med"},{"key":"1700_CR9","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3389\/fnagi.2019.00311","volume":"11","author":"A Chakravorty","year":"2019","unstructured":"Chakravorty A, Jetto CT, Manjithaya R (2019) Dysfunctional mitochondria and mitophagy as drivers of Alzheimer\u2019s disease pathogenesis. Front Aging Neurosci 11:311","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"1700_CR10","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/alz.12675","volume":"19","author":"R Chang","year":"2022","unstructured":"Chang R, Trushina E, Zhu K et al (2022) Predictive metabolic networks reveal sex- and APOE genotype-specific metabolic signatures and drivers for precision medicine in Alzheimer\u2019s disease. Alzheimers Dement 19(2):518\u2013531","journal-title":"Alzheimers Dement"},{"issue":"12","key":"1700_CR11","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.3390\/biom14121550","volume":"14","author":"K Cross","year":"2024","unstructured":"Cross K, Vetter SW, Alam Y, Hasan MZ, Nath AD, Leclerc E (2024) Role of the receptor for advanced glycation end products (RAGE) and its ligands in inflammatory responses. Biomolecules 14(12):1550","journal-title":"Biomolecules"},{"key":"1700_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/neuroglia4030015","author":"JVR Cruz","year":"2023","unstructured":"Cruz JVR, Batista C, Diniz LP, Mendes FA (2023) The role of astrocytes and blood\u2013brain barrier disruption in Alzheimer\u2019s disease. Neuroglia. https:\/\/doi.org\/10.3390\/neuroglia4030015","journal-title":"Neuroglia"},{"issue":"2","key":"1700_CR13","first-page":"159","volume":"6","author":"MS Dabour","year":"2024","unstructured":"Dabour MS, George MY, Daniel MR, Blaes AH, Zordoky BN (2024) The cardioprotective and anticancer effects of SGLT2 inhibitors: JACC: cardiooncology state-of-the-art review. JACC: CardioOncology 6(2):159\u2013182","journal-title":"JACC: CardioOncology"},{"key":"1700_CR14","doi-asserted-by":"crossref","first-page":"1287750","DOI":"10.3389\/fphar.2023.1287750","volume":"14","author":"L Dan","year":"2024","unstructured":"Dan L, Hao Y, Li J, Wang T, Zhao W, Wang H, Qiao L, Xie P (2024) Neuroprotective effects and possible mechanisms of berberine in animal models of alzheimer\u2019s disease: a systematic review and meta-analysis. Front Pharmacol 14:1287750 (PMID: 38259291; PMCID: PMC10800531)","journal-title":"Front Pharmacol"},{"issue":"1","key":"1700_CR15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.apsb.2024.10.004","volume":"15","author":"UC Dash","year":"2025","unstructured":"Dash UC, Bhol NK, Swain SK, Samal RR, Nayak PK, Raina V, Panda SK, Kerry RG, Duttaroy AK, Jena AB (2025) Oxidative stress and inflammation in the pathogenesis of neurological disorders: mechanisms and implications. Acta Pharm Sin B 15(1):15\u201334","journal-title":"Acta Pharm Sin B"},{"issue":"6","key":"1700_CR16","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1177\/193229680800200619","volume":"2","author":"SM de la Monte","year":"2008","unstructured":"de la Monte SM, Wands JR (2008) Alzheimer\u2019s disease is type 3 diabetes\u2014evidence reviewed. J Diabetes Sci Technol 2(6):1101\u20131113. https:\/\/doi.org\/10.1177\/193229680800200619","journal-title":"J Diabetes Sci Technol"},{"key":"1700_CR17","doi-asserted-by":"crossref","first-page":"805046","DOI":"10.3389\/fnins.2022.805046","volume":"16","author":"A El Idrissi","year":"2022","unstructured":"El Idrissi A, del Alonso A C (2022) Pathological human Tau induces alterations in the brain insulin signaling cascade. Front NeuroSci 16:805046","journal-title":"Front NeuroSci"},{"key":"1700_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/alz.069266","author":"B Eyre","year":"2022","unstructured":"Eyre B, Shabir O, Lee L, Francis S, Howarth C, Berwick J (2022) How does Alzheimer\u2019s disease, atherosclerosis, and comorbid Alzheimer\u2019s disease and atherosclerosis impact neurovascular function? Alzheimers Dement. https:\/\/doi.org\/10.1002\/alz.069266","journal-title":"Alzheimers Dement"},{"issue":"1","key":"1700_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-018-0453-0","volume":"11","author":"GD Femminella","year":"2019","unstructured":"Femminella GD et al (2019) Assessing the impact of GLP-1 analog liraglutide on alzheimer\u2019s dementia: a pilot study. Alzheimer\u2019s Res Therapy 11(1):1\u20139","journal-title":"Alzheimer\u2019s Res Therapy"},{"key":"1700_CR20","volume":"179","author":"F Gao","year":"2024","unstructured":"Gao F, Du W, Guo C, Geng P, Liu W, Jin X (2024) \u03b17nACh receptor: a promising target to reduce BBB damage by regulating inflammation and autophagy after ischemic stroke. Biomed Pharmacother 179:117337","journal-title":"Biomed Pharmacother"},{"key":"1700_CR21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceca.2023.102757","volume":"113","author":"P Garcia-Casas","year":"2023","unstructured":"Garcia-Casas P, Rossini M, Filadi R, Pizzo P (2023) Mitochondrial ca\u00b2\u207a signaling and Alzheimer\u2019s disease: too much or too little? Cell Calcium 113:102757","journal-title":"Cell Calcium"},{"issue":"7","key":"1700_CR22","doi-asserted-by":"crossref","DOI":"10.3390\/biom11071012","volume":"11","author":"JA Godoy","year":"2021","unstructured":"Godoy JA, R\u00edos JA, Pic\u00f3n-Pag\u00e8s P, Herrera-Fern\u00e1ndez V, Swaby B, Crepin G, Vicente R, Fern\u00e1ndez-Fern\u00e1ndez JM, Mu\u00f1oz FJ (2021) Mitostasis, calcium and free radicals in health, aging and neurodegeneration. Biomolecules 11(7):1012","journal-title":"Biomolecules"},{"key":"1700_CR23","first-page":"370","volume":"14","author":"Y Guan","year":"2023","unstructured":"Guan Y, Li J, Gu Y, Ji X (2023) Effects of hypoxia on cerebral microvascular angiogenesis: benefits or damages? Aging Dis 14:370\u2013385","journal-title":"Aging Dis"},{"issue":"23","key":"1700_CR24","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232315287","volume":"23","author":"R Hamz\u00e9","year":"2022","unstructured":"Hamz\u00e9 R, Delangre E, Tolu S, Moreau M, Janel N, Bailbe D, Movassat J (2022) Type 2 diabetes mellitus and Alzheimer\u2019s disease: shared molecular mechanisms and potential common therapeutic targets. Int J Mol Sci 23(23):15287","journal-title":"Int J Mol Sci"},{"issue":"19","key":"1700_CR25","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.3390\/cells11193107","volume":"11","author":"M Heimke","year":"2022","unstructured":"Heimke M, Lenz F, Rickert U, Lucius R, Cossais F (2022) Anti-inflammatory properties of the SGLT2 inhibitor empagliflozin in activated primary microglia. Cells 11(19):3107","journal-title":"Cells"},{"key":"1700_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-025-02939-9","author":"MT Heneka","year":"2025","unstructured":"Heneka MT, Gauthier S, Chandekar SA et al (2025) Neuroinflammatory fluid biomarkers in patients with Alzheimer\u2019s disease: a systematic literature review. Mol Psychiatry. https:\/\/doi.org\/10.1038\/s41380-025-02939-9","journal-title":"Mol Psychiatry"},{"issue":"9","key":"1700_CR27","volume":"13","author":"AL Hobday","year":"2021","unstructured":"Hobday AL, Parmar MS (2021) The link between diabetes mellitus and tau hyperphosphorylation: implications for risk of Alzheimer\u2019s disease. Cureus 13(9):e18362","journal-title":"Cureus"},{"issue":"1","key":"1700_CR28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/pathophysiology32010009","volume":"32","author":"FN Iheagwam","year":"2025","unstructured":"Iheagwam FN, Joseph AJ, Adedoyin ED, Iheagwam OT, Ejoh SA (2025) Mitochondrial dysfunction in diabetes: shedding light on a widespread oversight. Pathophysiology 32(1):9","journal-title":"Pathophysiology"},{"issue":"3","key":"1700_CR29","doi-asserted-by":"crossref","first-page":"106420","DOI":"10.1016\/j.jbc.2024.106420","volume":"300","author":"P Jadiya","year":"2024","unstructured":"Jadiya P, Kaye SD, Raghav D, Kadam A, Elrod JW, Tomar D (2024) Preserving bioenergetics through mitochondrial calcium homeostasis in Alzheimer\u2019s disease. J Biol Chem 300(3):106420","journal-title":"J Biol Chem"},{"key":"1700_CR30","doi-asserted-by":"crossref","first-page":"1144093","DOI":"10.3389\/fphar.2023.1144093","volume":"14","author":"A Kalani","year":"2023","unstructured":"Kalani A, Chaturvedi P, Brunetti D, Kalani K (2023) Editorial: mitochondrial therapy in neurodegeneration. Front Pharmacol 14:1144093","journal-title":"Front Pharmacol"},{"issue":"3","key":"1700_CR31","doi-asserted-by":"crossref","first-page":"950","DOI":"10.3390\/molecules27030950","volume":"27","author":"AAS Karthikeyan","year":"2022","unstructured":"Karthikeyan AAS, Singh S, Kukreti R, Saso L, Kukreti S (2022) Mechanistic insight into oxidative stress-triggered signaling pathways and type 2 diabetes. Molecules 27(3):950","journal-title":"Molecules"},{"issue":"22","key":"1700_CR32","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252211955","volume":"25","author":"M Kciuk","year":"2024","unstructured":"Kciuk M, Kruczkowska W, Ga\u0142\u0119ziewska J, Wanke K, Ka\u0142uzi\u0144ska-Ko\u0142at \u017b, Aleksandrowicz M, Kontek R (2024) Alzheimer\u2019s disease as type 3 diabetes: understanding the link and implications. Int J Mol Sci 25(22):11955","journal-title":"Int J Mol Sci"},{"issue":"19","key":"1700_CR33","doi-asserted-by":"crossref","first-page":"14450","DOI":"10.3390\/ijms241914450","volume":"24","author":"A Khan","year":"2023","unstructured":"Khan A, Ali T, Rehman SU, Kim MO (2023) Mitochondria and oxidative stress as a link between Alzheimer\u2019s disease and diabetes mellitus. Int J Mol Sci 24(19):14450","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1700_CR34","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2174\/1570159X20666220922153903","volume":"21","author":"S Koerich","year":"2022","unstructured":"Koerich S, Parreira GM, de Almeida DL, Vieira RP, de Oliveira ACP (2022) Receptors for advanced glycation end products (RAGE): promising targets aiming at the treatment of neurodegenerative conditions. Curr Neuropharmacol 21(2):219\u2013234","journal-title":"Curr Neuropharmacol"},{"issue":"9","key":"1700_CR35","first-page":"e44763","volume":"15","author":"M Koshatwar","year":"2023","unstructured":"Koshatwar M, Acharya S, Prasad R et al (2023) Exploring the potential of antidiabetic agents as therapeutic approaches for alzheimer\u2019s and parkinson\u2019s diseases: a comprehensive review. Cureus 15(9):e44763","journal-title":"Cureus"},{"key":"1700_CR36","doi-asserted-by":"crossref","first-page":"1144036","DOI":"10.3389\/fnagi.2023.1144036","volume":"15","author":"RL Lee","year":"2023","unstructured":"Lee RL, Funk KE (2023) Imaging blood\u2013brain barrier disruption in neuroinflammation and Alzheimer\u2019s disease. Front Aging Neurosci 15:1144036","journal-title":"Front Aging Neurosci"},{"key":"1700_CR37","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00040.2024","author":"E Lemche","year":"2025","unstructured":"Lemche E, Hortob\u00e1gyi T, Kiecker C, Turkheimer F (2025) Neuropathological links between T2DM and LOAD: systematic review and meta-analysis. Physiol Rev. https:\/\/doi.org\/10.1152\/physrev.00040.2024","journal-title":"Physiol Rev"},{"issue":"1","key":"1700_CR38","volume":"26","author":"W Li","year":"2025","unstructured":"Li W, Chen Q, Peng C, Yang D, Liu S, Lv Y, Jiang L, Xu S, Huang L (2025) Roles of the receptor for advanced glycation end products and its ligands in the pathogenesis of Alzheimer\u2019s disease. Int J Mol Sci 26(1):403","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1700_CR39","first-page":"1","volume":"1","author":"X Lipaj","year":"2024","unstructured":"Lipaj X (2024) Dementia: an interdisciplinary challenge of the present and future. Socialsciencesand Humanities:Corpus Open Access Journal(SHCOAJ) 1(1):1\u20134","journal-title":"Socialsciencesand Humanities:Corpus Open Access Journal(SHCOAJ)"},{"issue":"4","key":"1700_CR40","first-page":"442","volume":"138","author":"T Liu","year":"2025","unstructured":"Liu T, Jin C, Sun J, Zhu L, Wang C, Xiao F, Liu X, Lv L, Yang X, Zhou W, Tan C, Wang X, Wei W (2025) Paroxetine alleviates dendritic cell and T lymphocyte activation via GRK2-mediated PI3K-AKT signaling in rheumatoid arthritis. Chin Med J (Engl) 138(4):442\u2013450","journal-title":"Chin Med J (Engl)"},{"key":"1700_CR41","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.2147\/RMHP.S506581","volume":"18","author":"Y Ma","year":"2025","unstructured":"Ma Y, Huang S, Dong Y, Jin Q (2025) Global burden of Alzheimer\u2019s disease attributable to high fasting plasma glucose: epidemiological trends and machine learning insights. Risk Manag Healthc Policy 18:1291\u20131307","journal-title":"Risk Manag Healthc Policy"},{"key":"1700_CR42","unstructured":"Mayer MG, Fischer T (2025) Shared mechanisms of blood\u2013brain barrier dysfunction and neuroinflammation in COVID-19 and Alzheimer\u2019s disease. Am J Pathol. Epub ahead of print"},{"key":"1700_CR43","unstructured":"Meglio M (2024) Intranasal insulin and empagliflozin demonstrate therapeutic potential as combination treatment for Alzheimer disease. NeurologyLive. Published October 31, 2024"},{"issue":"5","key":"1700_CR44","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcac243","volume":"4","author":"R Molina-Fern\u00e1ndez","year":"2022","unstructured":"Molina-Fern\u00e1ndez R, Pic\u00f3n-Pag\u00e8s P, Barranco-Almohalla A, Crepin G, Herrera-Fern\u00e1ndez V, Garc\u00eda-El\u00edas A, Fanlo-Ucar H, Fern\u00e0ndez-Busquets X, Garc\u00eda-Ojalvo J, Oliva B, Mu\u00f1oz FJ (2022) Differential regulation of insulin signalling by monomeric and oligomeric amyloid beta-peptide. Brain Commun 4(5):fcac243","journal-title":"Brain Commun"},{"issue":"16","key":"1700_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23169328","volume":"23","author":"C Mor\u00e9n","year":"2022","unstructured":"Mor\u00e9n C, deSouza RM, Giraldo DM, Uff C (2022) Antioxidant therapeutic strategies in neurodegenerative diseases. Int J Mol Sci 23(16):9328. https:\/\/doi.org\/10.3390\/ijms23169328","journal-title":"Int J Mol Sci"},{"key":"1700_CR46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clnesp.2023.12.146","volume":"60","author":"SM Mousavi","year":"2024","unstructured":"Mousavi SM, Rahmani J, Varkaneh HK, Fatahi S, Clark CCT, Miraghajani M (2024) The role of adiponectin in Alzheimer\u2019s disease: a systematic review and meta-analysis. Clin Nutr ESPEN 60:1\u20138","journal-title":"Clin Nutr ESPEN"},{"key":"1700_CR47","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.bbi.2025.04.003","volume":"128","author":"J Moussiopoulou","year":"2025","unstructured":"Moussiopoulou J, Yakimov V, Roell L, Rauchmann BS, Toth H, Melcher J, J\u00e4ger I, Lutz I, Kallweit MS, Papazov B, Boudriot E, Seelos K, Dehsarvi A, Campana M, Raabe F, Maurus I, L\u00f6hrs L, Brendel M, St\u00f6cklein S, Falkai P, Hasan A, Group CW, Franzmeier N, Keeser D, Wagner E (2025) Higher blood\u2013brain barrier leakage in schizophrenia-spectrum disorders: a comparative dynamic contrast-enhanced magnetic resonance imaging study with healthy controls. Brain Behav Immun 128:256\u2013265","journal-title":"Brain Behav Immun"},{"issue":"14","key":"1700_CR48","first-page":"1","volume":"34","author":"TT Nguyen","year":"2020","unstructured":"Nguyen TT et al (2020) Oxidative stress in metabolic disorders: pathogenesis and therapeutic strategies. Antioxid Redox Signal 34(14):1\u201325","journal-title":"Antioxid Redox Signal"},{"key":"1700_CR49","doi-asserted-by":"crossref","first-page":"638686","DOI":"10.3389\/fncel.2021.638686","volume":"15","author":"J Ni","year":"2021","unstructured":"Ni J, Wu Z (2021) Inflammation spreading: negative spiral linking systemic inflammatory disorders and Alzheimer\u2019s disease. Front Cell Neurosci 15:638686","journal-title":"Front Cell Neurosci"},{"issue":"s1","key":"1700_CR50","doi-asserted-by":"publisher","first-page":"S95","DOI":"10.3233\/JAD-190048","volume":"72","author":"DMA Oliver","year":"2019","unstructured":"Oliver DMA, Reddy PH (2019) Molecular basis of Alzheimer\u2019s disease: focus on mitochondria. J Alzheimers Dis 72(s1):S95\u2013S116. https:\/\/doi.org\/10.3233\/JAD-190048","journal-title":"J Alzheimers Dis"},{"key":"1700_CR51","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3233\/ADR-220021","volume":"6","author":"VN Patel","year":"2022","unstructured":"Patel VN, Chorawala MR, Shah M, Shah K, Dave BP, Shah MP, Patel TM (2022) Emerging pathophysiological mechanisms linking diabetes mellitus and Alzheimer\u2019s disease: an old wine in a new bottle. J Alzheimers Dis Rep 6:349\u2013357","journal-title":"J Alzheimers Dis Rep"},{"issue":"8","key":"1700_CR52","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1007\/s12035-021-02365-2","volume":"58","author":"S Paul","year":"2021","unstructured":"Paul S, Saha D, Bk B, Bk B (2021) Mitochondrial dysfunction and mitophagy closely cooperate in neurological deficits associated with alzheimer\u2019s disease and type 2 diabetes. Mol Neurobiol 58(8):3677\u20133691","journal-title":"Mol Neurobiol"},{"issue":"16","key":"1700_CR53","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.2174\/0113862073269336231009110313","volume":"27","author":"Z Paul","year":"2024","unstructured":"Paul Z, Malla A, Dar M, Masoodi M (2024) Phytochemistry and pharmacological activity of Malva sylvestris L: a detailed insight. Comb Chem High Throughput Screen 27(16):2309\u20132322","journal-title":"Comb Chem High Throughput Screen"},{"issue":"7","key":"1700_CR54","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1080\/15376516.2024.2350595","volume":"34","author":"MJ Piao","year":"2024","unstructured":"Piao MJ, Kang KA, Fernando PDSM, Herath HMUL, Hyun JW (2024) Silver nanoparticle-induced cell damage via impaired mtROS-JNK\/MnSOD signaling pathway. Toxicol Mech Methods 34(7):803\u2013812","journal-title":"Toxicol Mech Methods"},{"issue":"5","key":"1700_CR55","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1021\/acs.chemrestox.6b00034","volume":"29","author":"A Pinkas","year":"2016","unstructured":"Pinkas A, Aschner M (2016) Advanced glycation end-products and their receptors: related pathologies, recent therapeutic strategies, and a potential model for future neurodegeneration studies. Chem Res Toxicol 29(5):707\u2013714","journal-title":"Chem Res Toxicol"},{"key":"1700_CR56","doi-asserted-by":"publisher","DOI":"10.15586\/alzheimersdisease.2019.ch1","volume-title":"Alzheimer\u2019s disease","author":"B Polis","year":"2019","unstructured":"Polis B, Samson AO (2019) A New Perspective on Alzheimer\u2019s disease as a Brain Expression of a Complex Metabolic Disorder. In: Wisniewski T (ed) Alzheimer\u2019s disease. Codon, Brisbane (AU). Chapter 1 doi:https:\/\/doi.org\/10.15586\/alzheimersdisease.2019.ch1"},{"issue":"8","key":"1700_CR57","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.3390\/antiox10081257","volume":"10","author":"MA Potenza","year":"2021","unstructured":"Potenza MA, Sgarra L, Desantis V, Nacci C, Montagnani M (2021) Diabetes and alzheimer\u2019s disease: might mitochondrial dysfunction help deciphering the common path? Antioxidants 10(8):1257","journal-title":"Antioxidants"},{"key":"1700_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.bionps.2025.100125","author":"G Reid","year":"2025","unstructured":"Reid G, Sargent B, Bauermeister S, Adler A, Koychev I (2025) A systematic review of in vivo brain insulin resistance biomarkers in humans. Biomarkers in Neuropsychiatry. https:\/\/doi.org\/10.1016\/j.bionps.2025.100125","journal-title":"Biomarkers in Neuropsychiatry"},{"issue":"1","key":"1700_CR59","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3233\/ADR-220021","volume":"6","author":"J Ricke","year":"2022","unstructured":"Ricke J (2022) Emerging pathophysiological mechanisms linking diabetes mellitus and Alzheimer\u2019s disease: an old wine in a new bottle. J Alzheimers Dis Rep 6(1):349\u2013357","journal-title":"J Alzheimers Dis Rep"},{"key":"1700_CR60","doi-asserted-by":"crossref","first-page":"1128619","DOI":"10.3389\/fnagi.2023.1128619","volume":"15","author":"SL Rossi","year":"2023","unstructured":"Rossi SL, Subramanian P, Bovenkamp DE (2023) The future is precision medicine-guided diagnoses, preventions and treatments for neurodegenerative diseases. Front Aging Neurosci 15:1128619","journal-title":"Front Aging Neurosci"},{"key":"1700_CR61","doi-asserted-by":"crossref","DOI":"10.1042\/NS20230016","volume":"7","author":"H Rowland","year":"2023","unstructured":"Rowland H, Moxon SR, Corbett NJ, Hanson KA, Fisher K, Kellett KAB, Hooper NM (2023) Inhibition of insulin-degrading enzyme in human neurons promotes amyloid-\u03b2 deposition. Neuronal Signal 7:ns20230016","journal-title":"Neuronal Signal"},{"key":"1700_CR62","doi-asserted-by":"publisher","first-page":"205","DOI":"10.2478\/amma-2024-0030","volume":"70","author":"PD Saragea","year":"2024","unstructured":"Saragea PD (2024) The genetic landscape of early and late-onset Alzheimer\u2019s disease: a review. Acta Marisiensis-Ser Med 70:205\u2013215. https:\/\/doi.org\/10.2478\/amma-2024-0030","journal-title":"Acta Marisiensis-Ser Med"},{"issue":"3","key":"1700_CR63","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3233\/JAD-230548","volume":"95","author":"NJ Schork","year":"2023","unstructured":"Schork NJ, Elman JA (2023) Pathway-specific polygenic risk scores correlate with clinical status and Alzheimer\u2019s disease-related biomarkers. J Alzheimers Dis 95(3):915\u2013929","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"1700_CR64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00210-024-03697-1","volume":"398","author":"MZ Shaaban","year":"2025","unstructured":"Shaaban MZ, Mostafa SA, Moshref AS, El-Hussein A, Ellakwa DE, Mehanny SS (2025) Mitochondrial-based therapies for neurodegenerative diseases: a review. Naunyn-Schmiedebergs Arch Pharmacol 398(1):1\u201315","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"1700_CR65","doi-asserted-by":"publisher","DOI":"10.1055\/a-2238-1384","author":"A Singh","year":"2024","unstructured":"Singh A, Ansari VA, Mahmood T, Hasan SM, Wasim R, Maheshwari S, Akhtar J, Sheikh S, Vishwakarma VK (2024) Targeting abnormal tau phosphorylation for Alzheimer\u2019s therapeutics. Horm Metab Res. https:\/\/doi.org\/10.1055\/a-2238-1384","journal-title":"Horm Metab Res"},{"key":"1700_CR66","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/bs.irn.2020.03.023","volume":"154","author":"G S\u00f6derbom","year":"2020","unstructured":"S\u00f6derbom G, Zeng BY (2020) The NLRP3 inflammasome as a bridge between neuro-inflammation in metabolic and neurodegenerative diseases. Int Rev Neurobiol 154:345\u2013391. https:\/\/doi.org\/10.1016\/bs.irn.2020.03.023. (Epub 2020 Jul 17. PMID: 32739011)","journal-title":"Int Rev Neurobiol"},{"key":"1700_CR67","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s12902-024-01731-0","volume":"24","author":"G Solela","year":"2024","unstructured":"Solela G, Gessesse HA, Zegeye H et al (2024) Prevalence, patterns, and determinants of vascular complications of type 2 diabetes in a teaching hospital in Addis Ababa, Ethiopia: a retrospective study. BMC Endocr Disord 24:190","journal-title":"BMC Endocr Disord"},{"key":"1700_CR68","doi-asserted-by":"publisher","unstructured":"Springer eBooks (2022) Advanced glycation end products in diabetes. Springer Nat 1\u201325. https:\/\/doi.org\/10.1007\/978-3-030-81303-1_8-1","DOI":"10.1007\/978-3-030-81303-1_8-1"},{"key":"1700_CR69","doi-asserted-by":"crossref","first-page":"903455","DOI":"10.3389\/fnagi.2022.903455","volume":"14","author":"Y Sun","year":"2022","unstructured":"Sun Y, Koyama Y, Shimada S (2022) Inflammation from peripheral organs to the brain: how does systemic inflammation cause neuroinflammation? Front Aging Neurosci 14:903455","journal-title":"Front Aging Neurosci"},{"issue":"10","key":"1700_CR70","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13101228","volume":"13","author":"F Superti","year":"2024","unstructured":"Superti F, Russo R (2024) Alpha-Lipoic acid: biological mechanisms and health benefits. Antioxidants 13(10):1228. https:\/\/doi.org\/10.3390\/antiox13101228","journal-title":"Antioxidants"},{"key":"1700_CR71","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","volume":"14","author":"MD Sweeney","year":"2018","unstructured":"Sweeney MD, Sagare AP, Zlokovic BV (2018) Blood\u2013brain barrier breakdown in Alzheimer\u2019s disease and other neurodegenerative disorders. Nat Rev Neurol 14:133\u2013150","journal-title":"Nat Rev Neurol"},{"key":"1700_CR72","unstructured":"Tomi\u0107 L (2020) Diabetes as a risk factor for neurodegenerative diseases. University Zagreb Medical School Repository. https:\/\/dabar.srce.hr\/en\/islandora\/object\/mef%3A3771"},{"issue":"8","key":"1700_CR73","doi-asserted-by":"crossref","DOI":"10.3390\/cells11081312","volume":"11","author":"A Twarda-Clapa","year":"2022","unstructured":"Twarda-Clapa A, Olczak A, Bia\u0142kowska A, Kozio\u0142kiewicz M (2022) Advanced glycation end-products (AGEs): formation, chemistry, classification, receptors, and diseases related to ages. Cells 11(8):1312","journal-title":"Cells"},{"issue":"5","key":"1700_CR74","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s12272-021-01332-8","volume":"44","author":"A Uprety","year":"2021","unstructured":"Uprety A, Kang Y, Kim SY (2021) Blood\u2013brain barrier dysfunction as a potential therapeutic target for neurodegenerative disorders. Arch Pharm Res 44(5):487\u2013498","journal-title":"Arch Pharm Res"},{"issue":"1","key":"1700_CR75","doi-asserted-by":"crossref","first-page":"44","DOI":"10.47310\/srjcms.2022.v02i01.010","volume":"2","author":"B Vijayam","year":"2022","unstructured":"Vijayam B, Balaji T, Balaji MS, Veerasamy S, Ganesan V (2022) The molecular mechanism of insulin resistance and glycogen synthase kinase 3\u03b2 in the progression of Alzheimer\u2019s disease in type 2 diabetes mellitus patients. Sci Res J Clin Med Sci 2(1):44\u201348","journal-title":"Sci Res J Clin Med Sci"},{"key":"1700_CR76","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1094356","volume":"11","author":"GC Walters","year":"2023","unstructured":"Walters GC, Usachev YM (2023) Mitochondrial calcium cycling in neuronal function and neurodegeneration. Front Cell Dev Biol 11:1094356","journal-title":"Front Cell Dev Biol"},{"issue":"19","key":"1700_CR77","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.3390\/cells11193001","volume":"11","author":"Y Wang","year":"2022","unstructured":"Wang Y, Zhang S, Li Y, Wang J, Chen Y, Wang Y et al (2022) Macrophages, chronic inflammation, and insulin resistance. Cells 11(19):3001","journal-title":"Cells"},{"issue":"6","key":"1700_CR78","first-page":"166631","volume":"1861","author":"W Wang","year":"2025","unstructured":"Wang W, Zhao F, Huang W (2025) Mitochondrial dysfunction in Alzheimer\u2019s disease. Biochim Et Biophys Acta - Mol Basis Disease 1861(6):166631","journal-title":"Biochim Et Biophys Acta - Mol Basis Disease"},{"issue":"12","key":"1700_CR79","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241210069","volume":"24","author":"M W\u0105troba","year":"2023","unstructured":"W\u0105troba M, Grabowska A, Szukiewicz D (2023) Effects of diabetes mellitus-related dysglycemia on the functions of blood\u2013brain barrier and the risk of dementia. Int J Mol Sci 24(12):10069","journal-title":"Int J Mol Sci"},{"issue":"11","key":"1700_CR80","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21114184","volume":"21","author":"KK Wu","year":"2020","unstructured":"Wu KK, Cheung SW, Cheng KK (2020) NLRP3 inflammasome activation in adipose tissues and its implications on metabolic diseases. Int J Mol Sci 21(11):4184. https:\/\/doi.org\/10.3390\/ijms21114184","journal-title":"Int J Mol Sci"},{"key":"1700_CR81","doi-asserted-by":"crossref","first-page":"1433750","DOI":"10.3389\/fendo.2024.1433750","volume":"15","author":"D Wu","year":"2024","unstructured":"Wu D, Zhang Y, Liu H, Li X, Zhang Y, Yang M et al (2024) Tirzepatide and dual GIP\/GLP-1 receptor agonists: the new era of type 2 diabetes treatment. Front Endocrinol 15:1433750","journal-title":"Front Endocrinol"},{"issue":"20","key":"1700_CR82","doi-asserted-by":"publisher","first-page":"7504","DOI":"10.1523\/JNEUROSCI.23-20-07504.2003","volume":"23","author":"Q Yan","year":"2003","unstructured":"Yan Q, Zhang J, Liu H, Babu-Khan S, Vassar R, Biere AL, Citron M, Landreth G (2003) Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of alzheimer\u2019s disease. J Neurosci 23(20):7504\u20137509. https:\/\/doi.org\/10.1523\/JNEUROSCI.23-20-07504.2003PMID: 12930788; PMCID: PMC6740758","journal-title":"J Neurosci"},{"key":"1700_CR83","first-page":"237","volume":"22","author":"H Yaribeygi","year":"2023","unstructured":"Yaribeygi H, Maleki M, Butler AE, Jamialahmadi T, Sahebkar A (2023) Brain insulin signaling and cognition: possible links. EXCLI J 22:237\u2013249","journal-title":"EXCLI J"},{"issue":"4","key":"1700_CR84","volume":"24","author":"JH Yoon","year":"2023","unstructured":"Yoon JH, Hwang J, Son SU, Choi J, You SW, Park H, Cha SY, Maeng S (2023) How can insulin resistance cause Alzheimer\u2019s disease? Int J Mol Sci 24(4):3506","journal-title":"Int J Mol Sci"},{"key":"1700_CR85","volume":"8","author":"W Zhang","year":"2023","unstructured":"Zhang W, Xiao D, Mao Q et al (2023) Role of neuroinflammation in neurodegeneration development. Signal Transduct Target Ther 8:267","journal-title":"Signal Transduct Target Ther"},{"issue":"7","key":"1700_CR86","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.3390\/molecules29071478","volume":"29","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Zhang Y, Wang X, Li J, Li W, Zhang Y et al (2024) Neuroinflammation of microglial regulation in alzheimer\u2019s disease: therapeutic approaches. Molecules 29(7):1478","journal-title":"Molecules"},{"key":"1700_CR87","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s40795-025-01038-w","volume":"11","author":"D Zooravar","year":"2025","unstructured":"Zooravar D, Soltani P, Khezri S (2025) Mediterranean diet and diabetic microvascular complications: a systematic review and meta-analysis. BMC Nutr 11:66","journal-title":"BMC Nutr"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-025-01700-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-025-01700-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-025-01700-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T10:59:19Z","timestamp":1761303559000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-025-01700-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":87,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["1700"],"URL":"https:\/\/doi.org\/10.1007\/s11011-025-01700-z","relation":{},"ISSN":["1573-7365"],"issn-type":[{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"10 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"276"}}